Pfenex Announces U.S. Commercial Launch of Teriparatide Injection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. BAC
2. NVDA
3. DPZ
4. GS
5. CRWV
6. UNH
7. ORCL
8. DRS
9. JPM
10. ACI

Go back to Pfenex Announces U.S. Commercial Launch of Teriparatide Injection

Pfenex Inc. (PFNX) PT Raised to $15 at Oppenheimer

June 15, 2020 9:19 AM EDT

Oppenheimer analyst Francois Brisebois raised the price target on Pfenex Inc. (NYSE: PFNX) to $15.00 (from $10.00) while maintaining a Outperform rating following the company's announcement that its commercial partner Alvogen opted to proceed with the US launch of PF708 to increase bone density in... More